Still feeling hungry on Mounjaro? Here's what's actually happening

Mounjaro (tirzepatide) lowers appetite through two gut-hormone pathways, but hunger doesn't disappear entirely — it typically shifts in intensity and timing rather than stopping altogether.
Dose, protein intake, eating pace and the type of foods you choose all affect how hungry you feel between injections, particularly in the first weeks of treatment.
Hunger that returns sharply in the days before your next injection is common; it tends to ease once the dose is established or titrated upward by your prescriber.
If persistent or unusual hunger is affecting your confidence in treatment, that conversation belongs with a clinician, not a forum.

Feeling hungry on Mounjaro is more common than most people expect, and it doesn't mean the medicine isn't working. Tirzepatide reduces appetite through GIP and GLP-1 receptor pathways, but hunger doesn't simply switch off — it changes character, arrives at different times, and can return for several recognisable reasons. These are prescription-only medicines, and any concerns about appetite or treatment progress are worth raising with your prescriber, who can look at the full clinical picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What your hunger on Mounjaro is actually telling you

The myth: Mounjaro should make you forget food entirely

This is the expectation that causes most of the worry. People starting tirzepatide sometimes hear that appetite simply vanishes, and then feel something has gone wrong when they finish a meal and still want more an hour later. The reality is different. Mounjaro slows gastric emptying and signals fullness through two receptor pathways, which means many people eat noticeably less before feeling satisfied, but the brain's hunger circuitry doesn't go quiet permanently. Appetite, in some form, is still part of being human.

What tends to change is the nature of hunger. The all-consuming, hard-to-ignore drive that many people describe before starting treatment often softens into something more manageable, a background signal rather than a demand. If what you're experiencing still feels close to the pre-treatment version, that's worth noting. Our guide on whether hunger on Mounjaro is normal explores this distinction in more detail.

The other thing worth knowing: the starter dose, 2.5mg, is chosen to help your system adjust gradually. Its job is tolerability, not full appetite suppression. Most of the meaningful effect builds as your prescriber titrates the dose over subsequent weeks.

Why hunger comes back before your next injection

One of the patterns prescribers hear about most often is hunger creeping back in the day or two before the weekly injection is due. This is a pharmacological reality. Tirzepatide's plasma concentration rises after each dose and then gradually falls toward the end of the week. As the concentration dips, the appetite-suppressing signal weakens slightly for some people.

This "end-of-week" hunger is not a sign that Mounjaro has stopped working. It usually settles as treatment continues and the dose reaches a level that maintains steadier coverage. If it's particularly pronounced, that's a clinical data point, the kind of thing worth mentioning at your next dose review rather than managing alone. You can read more about this pattern on our page covering hunger that persists on Mounjaro.

A quick check that takes under a minute: note roughly how many hours after your injection the hunger feels easiest to manage, and whether that window is narrowing or holding steady over successive weeks. That single observation gives your prescriber something concrete to work with.

Food choices, protein and eating pace all matter

What you eat on tirzepatide changes how hungry you feel in ways that go beyond calorie counts. Protein takes longer to digest and sustains fullness more reliably than refined carbohydrates; meals built around it tend to keep the appetite signal quiet for longer. Eating quickly can outrun the stomach's ability to signal fullness to the brain, a mechanism that tirzepatide doesn't override entirely. Slowing down gives gastric emptying, already lengthened by the medicine, time to do its job.

Fibre matters too. Vegetables, legumes and wholegrains expand in the stomach and slow digestion further. Our practical guide to eating on Mounjaro covers this in detail, including what to prioritise when appetite is small and nutritional needs still have to be met. For specific food questions (for example, whether everyday staples fit) our page on baked beans on Mounjaro gives you a real-world example of how to think about individual foods.

Hydration also plays a role that's easy to underestimate. Mild dehydration produces signals the brain reads as hunger; drinking water steadily through the day can reduce unnecessary appetite without any other change. The NHS tirzepatide medicines page covers the general dietary advice that supports treatment alongside these practical habits.

When to take persistent hunger to a clinician

Some hunger on Mounjaro is normal and manageable. There are situations, though, where it deserves clinical attention rather than self-troubleshooting. If your appetite feels no different from before starting treatment after several weeks at an established dose, our page on why you might still feel hungry on Mounjaro can help you understand the common reasons before you speak to a prescriber. If hunger is accompanied by symptoms that feel unusual (nausea, pain, significant fatigue) a prescriber needs to know. These medicines are clinically assessed and monitored for exactly that reason.

NICE's appraisal of tirzepatide, TA1026, includes a review criterion: if less than 5% weight loss has occurred after six months at the highest tolerated dose, the clinical team reviews whether continuing is appropriate. Persistent hunger that's limiting your progress is a relevant part of that conversation. It's not a failing, it's information. Our Mounjaro overview explains how the medicine works, and the team behind nume's clinical service reviews every repeat order before it's dispensed, which is precisely the moment to raise concerns like this.

If you'd like a prescriber to look at your situation properly, starting a free consultation is the straightforward next step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions